NCT06828276 Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants
| NCT ID | NCT06828276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Depressive Symptoms |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2025-03-25 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2025-03-25 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this randomized controlled trial (RCT) is to investigate the effectiveness of a culturally adapted internet-based cognitive behavioral therapy (i-CBT) intervention in reducing symptoms of common mental health issues among Farsi/Dari-speaking youth migrants and refugees. Investigator hypothesizes that there will be a significant decrease in psychological symptoms after participants receive the intervention compared to a control group.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 15 and 29. * A score above the cut-off 1.75 on HSCL-25 * Has a refugee or migrant background * Has a good and stable internet connection * Has access to a computer, tablet or smartphone * Is fluent in reading and writing Arabic * Has the ability to dedicate time to take part in the intervention for 6-10 weeks. Exclusion Criteria: * Is suffering from a severe mental illness, such as psychosis or severe depression. * Is suffering from substance abuse * Is undergoing a psychological treatment * Has a high risk of suicide
Contact & Investigator
Gerhard Andersson, PhD
PRINCIPAL INVESTIGATOR
Linkoeping University
Frequently Asked Questions
Who can join the NCT06828276 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 29 Years, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06828276 currently recruiting?
Yes, NCT06828276 is actively recruiting participants. Contact the research team at shervin.shahnavaz@ki.se for enrollment information.
Where is the NCT06828276 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT06828276 clinical trial?
NCT06828276 is sponsored by Karolinska Institutet. The principal investigator is Gerhard Andersson, PhD at Linkoeping University. The trial plans to enroll 128 participants.